Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Shares Outstanding (2021 - 2024)

Opus Genetics (IRD) has disclosed Shares Outstanding for 7 consecutive years, with $22.6 million as the latest value for Q3 2023.

  • On a quarterly basis, Shares Outstanding rose 8.69% to $22.6 million in Q3 2023 year-over-year; TTM through Sep 2023 was $22.6 million, a 8.69% increase, with the full-year FY2022 number at $20.9 million, up 10.69% from a year prior.
  • Shares Outstanding was $22.6 million for Q3 2023 at Opus Genetics, up from $21.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $22.6 million in Q3 2023 to a low of $10.9 million in Q1 2021.
  • A 3-year average of $19.0 million and a median of $20.1 million in 2022 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: surged 75.79% in 2022, then increased 4.41% in 2023.
  • Opus Genetics' Shares Outstanding stood at $18.8 million in 2021, then increased by 10.69% to $20.9 million in 2022, then rose by 8.38% to $22.6 million in 2023.
  • Per Business Quant, the three most recent readings for IRD's Shares Outstanding are $22.6 million (Q3 2023), $21.0 million (Q2 2023), and $20.9 million (Q1 2023).